Safety of enoxaparin in patients implanted with continuous flow left ventricular assist devices
There was no difference between bleeding and thromboembolic events in patients implanted with CF-LVADs prescribed LMWH or IV UFH for bridging of subtherapeutic INRs. Larger prospective randomized data are needed to validate these findings.
Authors
- Libby Orzel
- Bryan A. Whitson (ORCID: https://orcid.org/0000-0003-0040-3638)
- Rachel C. Klosko (ORCID: https://orcid.org/0000-0002-4934-1899)
- Eric McLaughlin (ORCID: https://orcid.org/0000-0003-2200-5905)
- Brent C. Lampert (ORCID: https://orcid.org/0000-0002-3368-7473)
Institutions
- Binghamton University (US)
- The Ohio State University Wexner Medical Center (US)
- The Ohio State University (US)
Publication Details
- Journal
- Artificial Organs
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1111/aor.14908
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ohio State University
- National Center for Advancing Translational Sciences